BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 36424079)

  • 1. Current and Future Biomarkers in the Management of Renal Cell Carcinoma.
    Reese S; Calderon L; Khaleel S; Hakimi AA
    Urol Clin North Am; 2023 Feb; 50(1):151-159. PubMed ID: 36424079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of Renal Cell Carcinoma: Promising Biomarkers and the Challenges to Reach the Clinic.
    Lyskjær I; Iisager L; Axelsen CT; Nielsen TK; Dyrskjøt L; Fristrup N
    Clin Cancer Res; 2024 Feb; 30(4):663-672. PubMed ID: 37874628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The genomics of renal cell carcinoma and its role in renal mass biopsy.
    Salami SS; George AK; Udager AM
    Curr Opin Urol; 2018 Jul; 28(4):383-391. PubMed ID: 29708949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kidney cancer biomarkers and targets for therapeutics: survivin (BIRC5), XIAP, MCL-1, HIF1α, HIF2α, NRF2, MDM2, MDM4, p53, KRAS and AKT in renal cell carcinoma.
    Li F; Aljahdali IAM; Zhang R; Nastiuk KL; Krolewski JJ; Ling X
    J Exp Clin Cancer Res; 2021 Aug; 40(1):254. PubMed ID: 34384473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on Biomarkers in Renal Cell Carcinoma.
    Saliby RM; Saad E; Kashima S; Schoenfeld DA; Braun DA
    Am Soc Clin Oncol Educ Book; 2024 Jan; 44(2):e430734. PubMed ID: 38207251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating adiponectin as a biomarker in renal cell carcinoma: a systematic review and meta-analysis.
    Yap NY; Yap FN; Perumal K; Rajandram R
    Biomarkers; 2019 Sep; 24(6):607-614. PubMed ID: 31215811
    [No Abstract]   [Full Text] [Related]  

  • 7. [Novel biomarkers in renal cell carcinoma. Identification and functional characterization].
    Macher-Göppinger S
    Pathologe; 2015 Nov; 36 Suppl 2():201-4. PubMed ID: 26362327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrence in Localized Renal Cell Carcinoma: a Systematic Review of Contemporary Data.
    Speed JM; Trinh QD; Choueiri TK; Sun M
    Curr Urol Rep; 2017 Feb; 18(2):15. PubMed ID: 28213859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genitourinary imaging: part 2, role of imaging in medical management of advanced renal cell carcinoma.
    Shinagare AB; Krajewski KM; Jagannathan JP; Ramaiya NH
    AJR Am J Roentgenol; 2012 Nov; 199(5):W554-64. PubMed ID: 23096199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic and Predictive Factors in Metastatic Renal Cell Carcinoma: Current Perspective and a Look Into the Future.
    Gan CL; Dudani S; Heng DYC
    Cancer J; 2020; 26(5):365-375. PubMed ID: 32947304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue biomarkers in renal cell carcinoma: issues and solutions.
    Di Napoli A; Signoretti S
    Cancer; 2009 May; 115(10 Suppl):2290-7. PubMed ID: 19402057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From Basic Science to Clinical Translation in Kidney Cancer: A Report from the Second Kidney Cancer Research Summit.
    Choueiri TK; Albiges L; Atkins MB; Bakouny Z; Bratslavsky G; Braun DA; Haas NB; Haanen JBAG; Hakimi AA; Jewett MAS; Jonasch E; Kaelin WG; Kapur P; Labaki C; Lewis B; McDermott DF; Pal SK; Pels K; Poteat S; Powles T; Rathmell WK; Rini BI; Signoretti S; Tannir NM; Uzzo RG; Hammers HJ
    Clin Cancer Res; 2022 Mar; 28(5):831-839. PubMed ID: 34965942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unlocking Precision Medicine: Liquid Biopsy Advancements in Renal Cancer Detection and Monitoring.
    Crocetto F; Falcone A; Mirto BF; Sicignano E; Pagano G; Dinacci F; Varriale D; Machiella F; Giampaglia G; Calogero A; Varlese F; Balsamo R; Trama F; Sciarra A; Del Giudice F; Busetto GM; Ferro M; Lucarelli G; Lasorsa F; Imbimbo C; Barone B
    Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarkers for the Detection and Surveillance of Renal Cancer.
    Nolazco JI; Soerensen SJC; Chung BI
    Urol Clin North Am; 2023 May; 50(2):191-204. PubMed ID: 36948666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Renal cell carcinoma].
    Fornara P; Hoda MR
    Urologe A; 2011 Sep; 50 Suppl 1():219-22. PubMed ID: 21837488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Renal cancer biomarkers. What is justified?].
    Moch H
    Pathologe; 2012 Nov; 33 Suppl 2():278-81. PubMed ID: 23052348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression profiling of renal cell carcinoma and its implications in diagnosis, prognosis, and therapeutics.
    Takahashi M; Sugimura J; Yang X; Vogelzang N; Teh BS; Furge K; Teh BT
    Adv Cancer Res; 2003; 89():157-81. PubMed ID: 14587873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RCDB: Renal Cancer Gene Database.
    Ramana J
    BMC Res Notes; 2012 May; 5():246. PubMed ID: 22608002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EAU guidelines on renal cell carcinoma: the 2010 update.
    Ljungberg B; Cowan NC; Hanbury DC; Hora M; Kuczyk MA; Merseburger AS; Patard JJ; Mulders PF; Sinescu IC;
    Eur Urol; 2010 Sep; 58(3):398-406. PubMed ID: 20633979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Possibilities of molecular diagnosis of renal cell carcinoma].
    Junker K
    Aktuelle Urol; 2014 Sep; 45(5):370-3. PubMed ID: 25230022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.